NASHVILLE, TN / ACCESSWIRE / February 22, 2021 / EV Biologics Corp, (OTC PINK:YECO), today announced that during its Q1 R&D meeting, the executive board reviewed and has approved a plan for cGMP ...
Successful PAT implementation should start small, with the goal of integrating data into decision-making and fostering cross-functional collaboration.
GEN: Your company maintains that the supply chain of single-use assemblies is the biggest bottleneck in biopharmaceutical manufacturing. Can you talk about why that is the case and how you address ...
Built-in data integrity is a bare minimum requirement in today’s BioPharmaceutical manufacturing. Good Manufacturing Practices (GMP) regulations of the Food and Drug Administration (FDA) highlight the ...
The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...
Multifidelity optimization can inform decision-making during process development and reduce the number of experiments ...
SOUTHPORT, N.C., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Cygnus Technologies, part of Maravai LifeSciences (Maravai) (NASDAQ: MRVI), the leading assay and services provider for the detection and ...
Industrial yeasts are a powerhouse of protein production, used to manufacture vaccines, biopharmaceuticals, and other useful compounds. In a new study, MIT chemical engineers have harnessed artificial ...
Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery to improve treatments for patients, today announced that ...
Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media. KAWASAKI, Japan & SANTA ANA, Calif., December 18, ...
NEWARK, Del. and ATLANTA, Nov. 12, 2025 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and the Open Applications Group, Inc. (OAGi) are proud to ...
Over the years, the biopharmaceutical market has grown into a prominent and promising segment of the overall pharmaceutical industry. Characterized by a number of blockbuster therapies (HUMIRA®, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results